The 6 analysts offering 1 year price forecasts for AND have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to AND in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
AND EPS for the last quarter is 0.41 CAD despite the estimation of 0.41 CAD. In the next quarter EPS is expected to reach 0.47 CAD. Track more of ANDLAUER HEALTHCARE GROUP INC financials and stay on top of what is up with the company.
According to analysts, AND price target is 47.50 CAD with a max estimate of 54.00 CAD and a min estimate of 42.00 CAD. Check if this forecast comes true in a year, meanwhile watch ANDLAUER HEALTHCARE GROUP INC stock price chart and keep track of the current situation with AND news and stock market news.
We've gathered opinions of 6 analysts rating AND stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.